CoChat

Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen

Open access

The DOI matches its Crossref record; 34 of the 35 references it cites were found in a registry or an index.

Abstract

The majority of patients with Alzheimer disease (AD) suffer from impaired cerebral circulation. Accumulating evidence suggests that fibrinogen, the main protein component of blood clots, plays an important role in this circulatory dysfunction in AD. Fibrinogen interacts with β-amyloid (Aβ), forming plasmin-resistant abnormal blood clots, and increased fibrin deposition is found in the brains of AD patients and mouse models. In this study, we investigated the biochemical and structural details of the Aβ-fibrinogen interaction. We identified the central region of Aβ42 as the most critical region for the interaction, which can be inhibited by specific antibodies against the central region of Aβ and by naturally occurring p3 peptides, Aβ17-40 and Aβ17-42. X-ray crystallographic analysis revealed that Aβ42 binding to fragment D of fibrinogen induced a structural change in the C-terminal region of the fibrinogen β-chain (β384-393). Furthermore, we identified an additional Aβ-binding site within the αC region of fibrinogen. Aβ binding to this αC region blocked plasmin-mediated fibrin cleavage at this site, resulting in the generation of increased levels of a plasmin-resistant fibrin degradation fragment. Overall, our study elucidates the Aβ-fibrinogen interaction and clarifies the mechanism by which Aβ-fibrinogen binding delays fibrinolysis by plasmin. These results may facilitate the development of effective therapeutics against the Aβ-fibrinogen interaction to treat cerebrovascular abnormalities in AD.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2016-03-705228

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 34 references

Cited by

See all 70

Metadata

Authors
Zamolodchikov, D., Berk-Rauch, H. E., Oren, D. A., Stor, D. S., Singh, P. K., Kawasaki, M., Aso, K., Strickland, S., & Ahn, H. J.
Affiliations
  • Patricia and John Rosenwald Laboratory of Neurobiology and Genetics and
  • Rockefeller University (US)
  • Tri-Institutional Therapeutics Discovery Institute (US)
Venue
Blood
Published
2016-08-25
Volume
128
Issue
8
Pages
1144-1151
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2486004346
Cited by
70
References
35
Citations by year
2026: 2 · 2025: 12 · 2024: 8 · 2023: 7 · 2022: 5 · 2021: 10 · 2020: 7 · 2019: 10 · 2018: 6 · 2017: 3
FWCI
5.10
Type
journal article
Language
en
Open access
Locations
  • Blood (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Rutgers University Community Repository (Rutgers University) (submittedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke (R01NS050537)
  • National Institute of Biomedical Imaging and Bioengineering (P30EB009998)
  • National Center for Research Resources (S10RR027037, S10RR022321)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Hematology › Blood properties and coagulation
  • Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
Keywords
amyloid-beta, fibrinogen, Alzheimer's disease, amyloid-beta 42, fibrinogen fragment D, plasmin resistance, fibrinolysis, cerebral circulation, cerebrovascular abnormalities, protein-protein interaction
MeSH terms
Amino Acid Sequence, Animals, Antibodies, Fibrin Fibrinogen Degradation Products, Fibrinogen, Fibrinolysin, Fibrinolysis, Humans, Protein Binding, Sodium Dodecyl Sulfate, Amyloid beta-Peptides, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen. https://app.cochat.ai/papers/10.1182/blood-2016-03-705228
The paper
Zamolodchikov, D., Berk-Rauch, H. E., Oren, D. A., Stor, D. S., Singh, P. K., Kawasaki, M., Aso, K., Strickland, S., & Ahn, H. J. (2016). Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen. Blood. https://doi.org/10.1182/blood-2016-03-705228

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.